CKD患者-话题@MedSci

#CKD患者#

47篇内容 | 2359人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1768847, encodeId=f5f81e6884757, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, objectTitle=Am J Kidney Dis：CKD患者2型糖尿病分析, objectType=article, longId=148459, objectId=b3471484595b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3471484595b, replyNumber=0, likeNumber=105, createdTime=2018-11-10, rootId=0, userName=12498f17m78暂无昵称, userId=9fa237912269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3471484595b, moduleTitle=Am J Kidney Dis：CKD患者2型糖尿病分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3471484595b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1768843, encodeId=c24d1e688432b, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, objectTitle=J Gen Intern Med：2型糖尿病合并CKD患者初始治疗：二甲双胍vs磺脲类, objectType=article, longId=135662, objectId=5f6e135662bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f6e135662bb, replyNumber=0, likeNumber=85, createdTime=2018-05-09, rootId=0, userName=12498f17m78暂无昵称, userId=9fa237912269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f6e135662bb, moduleTitle=J Gen Intern Med：2型糖尿病合并CKD患者初始治疗：二甲双胍vs磺脲类, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f6e135662bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1768840, encodeId=70671e6884045, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, objectTitle=Heart Rhythm：CKD患者射频消融治疗房颤期间：使用口服抗凝药还是华法林？, objectType=article, longId=133545, objectId=227f133545a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=227f133545a6, replyNumber=0, likeNumber=112, createdTime=2018-09-04, rootId=0, userName=12498f17m78暂无昵称, userId=9fa237912269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=227f133545a6, moduleTitle=Heart Rhythm：CKD患者射频消融治疗房颤期间：使用口服抗凝药还是华法林？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=227f133545a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1768841, encodeId=66f81e688416e, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, objectTitle=Nephrol Dial Transplant：3~4期CKD患者每天高剂量胆钙化醇治疗有何获益？, objectType=article, longId=134774, objectId=b1f6134e745d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1f6134e745d, replyNumber=0, likeNumber=63, createdTime=2018-11-11, rootId=0, userName=12498f17m78暂无昵称, userId=9fa237912269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1f6134e745d, moduleTitle=Nephrol Dial Transplant：3~4期CKD患者每天高剂量胆钙化醇治疗有何获益？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1f6134e745d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1768848, encodeId=324d1e6884875, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, objectTitle=J Lipid Res：CKD患者采用HDL预测心血管疾病风险并不可靠, objectType=article, longId=148986, objectId=7da614898656, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7da614898656, replyNumber=0, likeNumber=78, createdTime=2019-05-21, rootId=0, userName=12498f17m78暂无昵称, userId=9fa237912269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7da614898656, moduleTitle=J Lipid Res：CKD患者采用HDL预测心血管疾病风险并不可靠, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7da614898656)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1768846, encodeId=a39a1e6884631, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, objectTitle=Clin J Am Soc Nephrol：CKD患者是否需忌烟忌酒？, objectType=article, longId=147356, objectId=b84a14e356ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b84a14e356ef, replyNumber=0, likeNumber=78, createdTime=2019-06-21, rootId=0, userName=12498f17m78暂无昵称, userId=9fa237912269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b84a14e356ef, moduleTitle=Clin J Am Soc Nephrol：CKD患者是否需忌烟忌酒？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b84a14e356ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1768842, encodeId=af871e6884291, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, objectTitle=Clin J Am Soc Nephrol：CKD患者出院后给予药物治疗管理干预效果并不理想？, objectType=article, longId=135001, objectId=95ca13500148, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95ca13500148, replyNumber=0, likeNumber=81, createdTime=2018-10-05, rootId=0, userName=12498f17m78暂无昵称, userId=9fa237912269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95ca13500148, moduleTitle=Clin J Am Soc Nephrol：CKD患者出院后给予药物治疗管理干预效果并不理想？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95ca13500148)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1768839, encodeId=156a1e6883924, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, objectTitle=Am J Kidney Dis：社区药师在降低CKD患者心血管风险方面的作用, objectType=article, longId=127317, objectId=a5d012e31726, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5d012e31726, replyNumber=0, likeNumber=109, createdTime=2018-09-20, rootId=0, userName=12498f17m78暂无昵称, userId=9fa237912269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5d012e31726, moduleTitle=Am J Kidney Dis：社区药师在降低CKD患者心血管风险方面的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5d012e31726)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1768834, encodeId=8fd71e6883429, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, objectTitle=KIDNEY INT：补充维生素D对CKD患者血管功能的影响！, objectType=article, longId=104296, objectId=2a53104296a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a53104296a6, replyNumber=0, likeNumber=76, createdTime=2018-04-19, rootId=0, userName=12498f17m78暂无昵称, userId=9fa237912269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a53104296a6, moduleTitle=KIDNEY INT：补充维生素D对CKD患者血管功能的影响！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a53104296a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1768835, encodeId=ec971e6883560, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, objectTitle=Am J Kidney Dis：社区药师培训和沟通网络能改善CKD患者药物相关问题吗？, objectType=article, longId=114297, objectId=76a111429e95, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76a111429e95, replyNumber=0, likeNumber=88, createdTime=2018-01-14, rootId=0, userName=12498f17m78暂无昵称, userId=9fa237912269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76a111429e95, moduleTitle=Am J Kidney Dis：社区药师培训和沟通网络能改善CKD患者药物相关问题吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76a111429e95)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1768838, encodeId=3be01e688382b, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, objectTitle=JASN：纵向FGF23的变化轨迹和CKD患者死亡率有关！, objectType=article, longId=122083, objectId=efeb12208351, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efeb12208351, replyNumber=0, likeNumber=79, createdTime=2018-03-12, rootId=0, userName=12498f17m78暂无昵称, userId=9fa237912269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efeb12208351, moduleTitle=JASN：纵向FGF23的变化轨迹和CKD患者死亡率有关！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efeb12208351)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1768836, encodeId=3cc31e6883678, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, objectTitle=Am J Kidney Dis：尿酸与CKD患者肾衰竭和死亡的风险分析！, objectType=article, longId=119743, objectId=3752119e43ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3752119e43ab, replyNumber=0, likeNumber=89, createdTime=2018-04-23, rootId=0, userName=12498f17m78暂无昵称, userId=9fa237912269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3752119e43ab, moduleTitle=Am J Kidney Dis：尿酸与CKD患者肾衰竭和死亡的风险分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3752119e43ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1768837, encodeId=946d1e6883757, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, objectTitle=Diabetes Obes Metab：2型糖尿病伴CKD患者使用西格列汀是否安全？, objectType=article, longId=121589, objectId=3306121589f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3306121589f7, replyNumber=0, likeNumber=75, createdTime=2018-11-03, rootId=0, userName=12498f17m78暂无昵称, userId=9fa237912269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3306121589f7, moduleTitle=Diabetes Obes Metab：2型糖尿病伴CKD患者使用西格列汀是否安全？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3306121589f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1768833, encodeId=d31b1e688330c, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, objectTitle=Ann Intern Med：CKD患者使用骨质疏松症药物的获益和风险仍“一头雾水”, objectType=article, longId=103982, objectId=8f2310398238, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f2310398238, replyNumber=0, likeNumber=82, createdTime=2018-03-09, rootId=0, userName=12498f17m78暂无昵称, userId=9fa237912269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f2310398238, moduleTitle=Ann Intern Med：CKD患者使用骨质疏松症药物的获益和风险仍“一头雾水”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f2310398238)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1768831, encodeId=feb51e68831eb, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, objectTitle=KIDNEY INT：炎症和高水平的FGF23是CKD患者死亡的独立危险因素！, objectType=article, longId=85391, objectId=111485391f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=111485391f1, replyNumber=0, likeNumber=84, createdTime=2017-01-27, rootId=0, userName=12498f17m78暂无昵称, userId=9fa237912269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=111485391f1, moduleTitle=KIDNEY INT：炎症和高水平的FGF23是CKD患者死亡的独立危险因素！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=111485391f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1768832, encodeId=5b061e68832c0, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, objectTitle=JASN：皮肤钠浓度与CKD患者左心室肥厚, objectType=article, longId=89624, objectId=cd06896241d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd06896241d, replyNumber=0, likeNumber=56, createdTime=2017-12-25, rootId=0, userName=12498f17m78暂无昵称, userId=9fa237912269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd06896241d, moduleTitle=JASN：皮肤钠浓度与CKD患者左心室肥厚, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd06896241d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1768830, encodeId=827c1e68830ba, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, objectTitle=专家点评：肾功能越差，CKD患者降胆固醇治疗的获益越小, objectType=article, longId=76958, objectId=b282e69580c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b282e69580c, replyNumber=0, likeNumber=70, createdTime=2016-11-24, rootId=0, userName=12498f17m78暂无昵称, userId=9fa237912269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b282e69580c, moduleTitle=专家点评：肾功能越差，CKD患者降胆固醇治疗的获益越小, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b282e69580c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1768829, encodeId=f4651e6882974, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, objectTitle=Nephrology：CKD患者长期服用阿托伐他汀并不能减弱氧化应激能力, objectType=article, longId=59225, objectId=f4c9592254a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4c9592254a, replyNumber=0, likeNumber=74, createdTime=2016-09-30, rootId=0, userName=12498f17m78暂无昵称, userId=9fa237912269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4c9592254a, moduleTitle=Nephrology：CKD患者长期服用阿托伐他汀并不能减弱氧化应激能力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4c9592254a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1768828, encodeId=482b1e6882843, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, objectTitle=Lancet Diab & Endo：刀尖上的舞蹈—盐皮质激素受体拮抗剂在CKD患者中的应用, objectType=article, longId=43635, objectId=0e4e43635a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e4e43635a6, replyNumber=0, likeNumber=71, createdTime=2015-01-06, rootId=0, userName=12498f17m78暂无昵称, userId=9fa237912269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e4e43635a6, moduleTitle=Lancet Diab & Endo：刀尖上的舞蹈—盐皮质激素受体拮抗剂在CKD患者中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e4e43635a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1768827, encodeId=4c9f1e6882732, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, objectTitle=控制CKD患者收缩压多少合适？, objectType=article, longId=38779, objectId=138938e7999, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=138938e7999, replyNumber=0, likeNumber=51, createdTime=2014-10-19, rootId=0, userName=12498f17m78暂无昵称, userId=9fa237912269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=138938e7999, moduleTitle=控制CKD患者收缩压多少合适？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=138938e7999)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CKD患者

2020-05-29

12498f17m78暂无昵称 (审核中...)

前往app查看评论内容

#CKD患者#

Am J Kidney Dis：CKD患者2型糖尿病分析

2018-11-10

12498f17m78暂无昵称 (审核中...)

前往app查看评论内容

#CKD患者#

J Gen Intern Med：2型糖尿病合并CKD患者初始治疗：二甲双胍vs磺脲类

2018-05-09

12498f17m78暂无昵称 (审核中...)

前往app查看评论内容

#CKD患者#

Heart Rhythm：CKD患者射频消融治疗房颤期间：使用口服抗凝药还是华法林？

2018-09-04

12498f17m78暂无昵称 (审核中...)

前往app查看评论内容

#CKD患者#

Nephrol Dial Transplant：3~4期CKD患者每天高剂量胆钙化醇治疗有何获益？

2018-11-11

12498f17m78暂无昵称 (审核中...)

前往app查看评论内容

#CKD患者#

J Lipid Res：CKD患者采用HDL预测心血管疾病风险并不可靠

2019-05-21

12498f17m78暂无昵称 (审核中...)

前往app查看评论内容

#CKD患者#

Clin J Am Soc Nephrol：CKD患者是否需忌烟忌酒？

2019-06-21

12498f17m78暂无昵称 (审核中...)

前往app查看评论内容

#CKD患者#

Clin J Am Soc Nephrol：CKD患者出院后给予药物治疗管理干预效果并不理想？

2018-10-05

12498f17m78暂无昵称 (审核中...)

前往app查看评论内容

#CKD患者#

Am J Kidney Dis：社区药师在降低CKD患者心血管风险方面的作用

2018-09-20

12498f17m78暂无昵称 (审核中...)

前往app查看评论内容

#CKD患者#

KIDNEY INT：补充维生素D对CKD患者血管功能的影响！

2018-04-19

12498f17m78暂无昵称 (审核中...)

前往app查看评论内容

#CKD患者#

Am J Kidney Dis：社区药师培训和沟通网络能改善CKD患者药物相关问题吗？

2018-01-14

12498f17m78暂无昵称 (审核中...)

前往app查看评论内容

#CKD患者#

JASN：纵向FGF23的变化轨迹和CKD患者死亡率有关！

2018-03-12

12498f17m78暂无昵称 (审核中...)

前往app查看评论内容

#CKD患者#

Am J Kidney Dis：尿酸与CKD患者肾衰竭和死亡的风险分析！

2018-04-23

12498f17m78暂无昵称 (审核中...)

前往app查看评论内容

#CKD患者#

Diabetes Obes Metab：2型糖尿病伴CKD患者使用西格列汀是否安全？

2018-11-03

12498f17m78暂无昵称 (审核中...)

前往app查看评论内容

#CKD患者#

Ann Intern Med：CKD患者使用骨质疏松症药物的获益和风险仍“一头雾水”

2018-03-09

12498f17m78暂无昵称 (审核中...)

前往app查看评论内容

#CKD患者#

KIDNEY INT：炎症和高水平的FGF23是CKD患者死亡的独立危险因素！

2017-01-27

12498f17m78暂无昵称 (审核中...)

前往app查看评论内容

#CKD患者#

JASN：皮肤钠浓度与CKD患者左心室肥厚

2017-12-25

12498f17m78暂无昵称 (审核中...)

前往app查看评论内容

#CKD患者#

专家点评：肾功能越差，CKD患者降胆固醇治疗的获益越小

2016-11-24

12498f17m78暂无昵称 (审核中...)

前往app查看评论内容

#CKD患者#

Nephrology：CKD患者长期服用阿托伐他汀并不能减弱氧化应激能力

2016-09-30

12498f17m78暂无昵称 (审核中...)

前往app查看评论内容

#CKD患者#

Lancet Diab & Endo：刀尖上的舞蹈—盐皮质激素受体拮抗剂在CKD患者中的应用

2015-01-06

12498f17m78暂无昵称 (审核中...)

前往app查看评论内容

#CKD患者#

控制CKD患者收缩压多少合适？

2014-10-19

科室
- - 订阅+
  - 更多科室
工具
服务